Sterling Biotech (Delisted) financials and balance sheet

BSE: 512299Pharmaceuticals & Biotechnology

Formerly Sterling Tea and Industries

Last traded ₹0.70 on 5 Nov 2018

Delisted on 3 Mar 2023.

10 years at a glance

Standalone: the listed company alone, without its subsidiaries. ₹ crore, years to December, then March.Sterling Biotech annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
  • Loss
A loss in 7 of the 8 years with results on record

Operating and net margin, per cent

  • Operating margin
  • Net margin

The company moved its year end from December to March: its last year to December on record ended in Dec 2014, its first year to March in Mar 2017.

The years either side of a change of basis do not compare. From the year to Mar 2019, GST replaced excise duty on 1 Jul 2017, and revenue before that day includes the duty.

Results for the year to Mar 2021

Standalone: the listed company alone, without its subsidiaries. ₹ crore.

From revenue to net profit

  1. Revenue343
  2. Materials and goods−234
  3. Employee costs−41
  4. Other expenses−30
  5. Operating profit38
  6. Depreciation−245
  7. Other income+75
  8. Finance costs−0.2
  9. Profit before tax−133
  10. Tax−711
  11. Net profit−844

Profit and loss

Standalone, ₹ crore, years to December, then March. No results on record for the years to Mar 2016 and Mar 2018.Sterling Biotech quarterly results

₹ croreDec 2011Dec 2012Dec 2013Dec 2014Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021
Revenue from operations1,671842722671–404–350346343
1,025687–556–388–306536305
Materials and goods bought880581512466–273–232233234
Employee costs5154–52–––494941
Other expenses9453–39–––2425530
Operating profit before depreciation646155–115–17–44−19038
Operating margin38.7%18.4%–17.1%–4.1%–12.6%−55.1%11.0%
Materials, % of revenue52.7%69.0%–69.4%–––66.5%67.3%68.2%
Employee costs, % of revenue3.0%6.4%–7.7%–––14.1%14.1%12.0%
Other expenses, % of revenue5.6%6.2%–5.7%–––6.8%73.7%8.8%
Depreciation and amortisation251260–277–264–246246245
Operating profit after depreciation395−105–−162–−247–−202−436−207
Other income–––––––2475
Finance costs270412438470–370–25900
Profit before one-off items and tax125−518−593−631–−617–−458−432−133
One-off items–––––––−3,010––
Profit before tax125−518−593−631–−617–−3,468−432−133
9−168−192−205–−204–−138–711
Net profit19−350−401−458–−412–−3,330−432−844
Net margin1.1%−41.6%−55.5%−68.2%–−102.1%–−952.8%−125.1%−246.2%
Materials, employee costs and other expenses are shown for the years they add up to operating expenses; for the year to Mar 2017 they do not, so they are left blank. Operating expenses, operating profit before depreciation and operating profit after depreciation are left blank for the year to Dec 2013: the statement does not state its depreciation, which operating profit is worked out from, so operating profit is not given.
Earlier years, Dec 2007 to Dec 2010
₹ croreDec 2007Dec 2008Dec 2009Dec 2010
Revenue from operations9111,1881,4471,627
502677933919
Materials and goods bought316425606801
Employee costs24354044
Other expenses16221728675
Operating profit before depreciation409511514708
Operating margin44.9%43.0%35.5%43.5%
Materials, % of revenue34.7%35.7%41.9%49.2%
Employee costs, % of revenue2.7%3.0%2.8%2.7%
Other expenses, % of revenue17.8%18.3%19.8%4.6%
Depreciation and amortisation86107123198
Operating profit after depreciation322404391510
Other income10–––
Finance costs4159149230
Profit before tax291345242280
951136971
Net profit184219237146
Net margin20.2%18.4%16.4%9.0%
Standalone, ₹ crore, years to December.

Per share

Standalone, ₹ per share, years to December, then March.

₹ per shareDec 2011Dec 2012Dec 2013Dec 2014Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021
Earnings per share₹0.72−₹13.06−₹14.96−₹16.82–−₹15.15–−₹122.36−₹15.89−₹31.00
Diluted earnings per share₹0.64−₹11.56−₹13.24−₹10.57–−₹9.52–−₹122.36−₹15.89−₹31.00
Market cap at the year end (₹ crore)571137229189–117––––

Ratios

Standalone, years to December, then March.

RatioDec 2011Dec 2012Dec 2013Dec 2014Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021
Revenue growth2.7%−49.6%−14.2%−7.2%––––−1.1%−0.9%
Operating profit growth−8.7%−76.1%––––––––
Net profit growth−86.9%–––––––––
Earnings per share growth−87.3%–––––––––
Interest cover1.5–––––––––
Interest cover is left blank for the years to Dec 2012, Dec 2014, Mar 2017, Mar 2019, Mar 2020 and Mar 2021: operating profit after depreciation is a loss, and a loss covers no interest bill.

Growth and returns over 3, 5 and 10 years

Standalone: the listed company alone, without its subsidiaries. Each window ends with the year to Mar 2021.

Measure5 years3 years
Operating margin, average−6.9%−10.5%
Net margin, average−356.5%−441.4%

Accounting checks

Standalone, years to December, then March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckDec 2011Dec 2012Dec 2013Dec 2014Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021
Effective tax ratePublished threshold 17.16 per cent7.43–––––––––
A threshold marked as ours has no published figure; it is the line we read the check against.